Key Study
American Academy of Periodontology best evidence consensus statement on the use of biologics in clinical practice
Gustavo Avila-Ortiz, Jeanne Ambruster, Shayan Barootchi, Leandro Chambrone, Chia-Yu Chen, Douglas R Dixon, Maria L Geisinger, William V Giannobile, Katie Goss, John C Gunsolley, Rick H Heard, David M Kim, George A Mandelaris, Alberto Monje, Marc L Nevins, Angela Palaiologou-Gallis, Paul S Rosen, E Todd Scheyer, Fernando Suarez-Lopez Del Amo, Lorenzo Tavelli, Diego Velasquez, Hom-Lay Wang, Brian L Mealey
J Periodontol. 2022 Dec;93(12):1763-1770
Disclaimer: These results are not guaranteed; individual outcomes may vary depending on patient circumstances. This information is for informational purposes only and may not reflect Geistlich’s official position, opinion, or recommendation. Treatment decisions are made at the physician’s discretion, based on the unique needs of each patient.
GEM 21S® has not been approved by the FDA for use in this indication, and the safety and effectiveness of GEM 21S® for use in this indication has not been established by the FDA.
J Periodontol. 2022 Dec;93(12):1763-1770
Disclaimer: These results are not guaranteed; individual outcomes may vary depending on patient circumstances. This information is for informational purposes only and may not reflect Geistlich’s official position, opinion, or recommendation. Treatment decisions are made at the physician’s discretion, based on the unique needs of each patient.
GEM 21S® has not been approved by the FDA for use in this indication, and the safety and effectiveness of GEM 21S® for use in this indication has not been established by the FDA.
GEM 21S®